|
You are here |
www.someweekendreading.blog | ||
| | | | |
www.fda.gov
|
|
| | | | | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV | |
| | | | |
publichealth.jhu.edu
|
|
| | | | | A new family of COVID variants are becoming dominant in the U.S. at a crucial time for vaccine decision-making. | |
| | | | |
news.mcmaster.ca
|
|
| | | | | Vaccines developed at McMaster target the lungs first. [...]Read More... | |
| | | | |
www.eeoc.gov
|
|
| | | Federal Sector Directives & Guidance | ||